Moderna Inc said the US Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunisation Practices voted to recommend the use of the company's COVID-19 vaccine on people 18 years of age and older.
The panel voted 11-0 in favour of the vaccine, the company said in a press release.
The vote result came a day after the Food and Drug Administration's authorisation for emergency use of Moderna's COVID-19 vaccine.
"ACIP recommendation is another step forward in our quest to address this devastating pandemic with a vaccine," Chief Executive Officer Stephane Bancel said in the release.
Moderna's is the second COVID-19 vaccine to receive approval in the United States after a similar vaccine from Pfizer Inc and German partner BioNTech SE got the green light for emergency use.
US distribution of Moderna's vaccine began on Saturday, with more than 3,700 sites due to start receiving and administering shots as soon as Monday.
Kuwait air defences deal with Iranian missile, drone attacks
Nepal to rebuild early-warning system on China border after deadly flood, sources say
Two Palestinian teens killed in West Bank raid by Israeli settlers, army
Latest Indonesian free meal poisoning outbreaks affect 800, lawmaker says
Chinese students marooned in floods unleashed by Typhoon Saudel's rains
US and Iran exchange attacks as lull in war appears over
Malta court clears businessman over murder of investigative journalist
Kuwait confirms no injuries after Iranian drone hits residential complex
